Side Effects of Combination Therapy of Peginterferon and Ribavirin for Chronic Hepatitis-C

Internal Medicine- Japan

doi 10.2169/internalmedicine.46.0289

Full Text

Abstract

Available in

Categories

Internal Medicine

Date

January 1, 2007

Authors

Fumitaka Suzuki

Yoshiyuki Suzuki

Yusuke Kawamura

Masahiro Kobayashi

Mariko Kobayashi

Hiromitsu Kumada

Publisher

Japanese Society of Internal Medicine

Related search

The Combination of Ribavirin and Peginterferon Is Superior to Peginterferon and Placebo for Children and Adolescents With Chronic Hepatitis C

Gastroenterology

Gastroenterology

English

Influence of HMG-CoA Reductase Inhibitor to Virological Response of Peginterferon/Ribavirin Combination Therapy in Chronic Hepatitis C

Acta Hepatologica Japonica

English

Peginterferon Alfa-2b and Ribavirin Therapy in Kuwaiti Patients With Chronic Hepatitis C Virus Infection

Eastern Mediterranean Health Journal

English

Pegylated Interferon and Ribavirin Combination Therapy for Chronic Hepatitis C Associated With Thyroid Dysfunction

Acta Hepatologica Japonica

English

Cost Effectiveness of Interferon or Peginterferon With Ribavirin for Histologically Mild Chronic Hepatitis C

Gastroenterology

English

The Effect of Pegylated Interferon-Alpha2b and Ribavirin Combination Therapy for Chronic Hepatitis C Infection in Elderly Patients

BMC Research Notes

Molecular Biology

English

Efficacy and Safety of Combination Therapy of Natural Human Interferon Beta and Ribavirin in Chronic Hepatitis C Patients

Internal Medicine

Internal Medicine

English

Optimum Ribavirin Exposure Overcomes Racial Disparity in Efficacy of Peginterferon and Ribavirin Treatment for Hepatitis C Genotype 1

American Journal of Gastroenterology

Gastroenterology

English

Sudden-Onset Sarcoidosis With Severe Dyspnea Developing During Pegylated Interferon and Ribavirin Combination Therapy for Chronic Hepatitis C

Turkish Journal of Gastroenterology

Gastroenterology

English